Axelle E Loriot (Axelle Loriot)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Dna Damage Response

Cell Cycle Arrest

Endoplasmic Reticulum Stress

Top Venues

RNA (New York, N.Y.)

Clinical cancer research : an official journal of the American Association for Cancer Research

de Duve Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

de Duve Institute

Belgium

Researcher :: Bioinformatics

Publications

Simon P Beyaert, Axelle E Loriot, Nicolas D G Huyghe, Rose M Goebbels, Antonella Mendola, Anne-Sophie Govaerts, Catherine Fortpied, Pamela Baldin, Lisa F Licitra, Yassine Lalami, Paul M J Clement, Jean-Pascal H Machiels, Sandra Schmitz
Tumor microenvironment modifications induced by afatinib in squamous cell carcinoma of the head and neck - a window-of-opportunity study (EORTC90111-24111). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alexandra L Degraeve, Vincent Haufroid, Axelle E Loriot, Laurent Gatto, Vanessa Andries, Lars Vereecke, Laure Elens, Laure B Bindels
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome 11 (1) (2023)
Nikenza Viceconte, Axelle E Loriot, Patrícia Lona Abreu, Marion Scheibe, Albert Fradera Sola, Falk Butter, Charles De Smet, Claus M Azzalin, Nausica Arnoult, Anabelle Decottignies
PAR-TERRA is the main contributor to telomeric repeat-containing RNA transcripts in normal and cancer mouse cells. RNA (New York, N.Y.) 27 (1) (2020)